Barclays’s Yarrow Bioscience YARW Stock Holding History

Barclays’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-3	Closed	-$92	–	5745
2026 Q2	$92	Buy	+3	New	+$97	﹤0.01%	5200
2024 Q4	–	Sell	-2	Closed	-$188	–	5504
2024 Q3	$188	Buy	+2	New	+$190	﹤0.01%	5167
2020 Q3	–	Sell	-35	Closed	-$219K	–	5614
2020 Q2	$219K	Buy	35 +29	+483%	+$196K	﹤0.01%	3996
2020 Q1	$59K	Buy	6 +2	+50%	+$31.4K	﹤0.01%	5124
2019 Q4	$73K	Buy	4 +2	+100%	+$33.3K	﹤0.01%	5621
2019 Q3	$35K	Sell	2 -1	-33%	-$16.1K	﹤0.01%	6062
2019 Q2	$62K	Buy	3 +2	+200%	+$49.5K	﹤0.01%	5992
2019 Q1	$27K	Buy	+1	New	+$24K	﹤0.01%	6236
2018 Q4	–	Sell	-1	Closed	-$22.4K	–	6843
2018 Q3	$37K	Buy	+1	New	+$30.9K	﹤0.01%	6236
2018 Q2	–	Hold	0	–	–	–	6710
2018 Q1	–	Hold	0	–	–	–	5909

Other funds holding YARW

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

MB, Levis & Associates Center Valley, Pennsylvania $273M AUM 8.08% 1-Year Est. Return

Hurley Capital New York $206M AUM 18.12% 1-Year Est. Return

Barclays's YARW Position: Q3 2026 in Review

Barclays sold out of Yarrow Bioscience (YARW) in Q3 2026, closing a stake of 3 shares — an estimated $92 sold.

Barclays first reported a position in YARW in Q3 2018 and held it in 9 quarters. The position peaked at $219K in Q2 2020. 8 funds tracked by Wall St. Rank hold YARW as of Q3 2026.

Barclays reported no remaining Yarrow Bioscience position as of Q3 2026 after selling out during the quarter.
Barclays sold 3 Yarrow Bioscience shares in Q3 2026, an estimated $92.
Barclays first reported a position in Yarrow Bioscience in Q3 2018 and held it in 9 quarters.
Barclays's Yarrow Bioscience position peaked at $219K in Q2 2020.
8 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.